title: [Erectile dysfunction. Are interdisciplinary diagnosis and therapy necessary?].
abstract: OBJECTIVE
  The last few decades have seen a marked increase in mean life expectancy in Central Europe. This has made elderly people and their quality of life a matter of ever-increasing medical concern. Besides the lack of population based studies in Central Europe, the identifying risk factors for the development of erectile dysfunction (ED) is crucial.
  
  
  METHODS
  A newly developed and validated questionnaire on male erectile dysfunction was mailed to a representative population sample of 8000 men 30 to 80 years of age in the Cologne urban district.
  
  
  RESULTS
  The response included 4489 analysable replies (56,1 %). The median age was 51,8 years. Prevalence of ED was estimated at about 19.2 %, with a steep age-related increase (2,3 - 53,4 %) Therapeutic necessity (defined by co-occurrence of ED and dissatisfaction with sex life), also increases with age. The overall number of ED sufferers seeking therapy was 6,8 %. The following illnesses where seen in the ED group: heart failure (14,7 %), pelvic surgery (18,8 %), diabetes mellitus (20,2 %), peripheral arterial circulatory disorders (21,5 %), herniated disc (23,2 %) and hypertension (32,0 %). Although the pathogenetic pathway remains unclear with a prevalence of 72 % "lower urinary tract symptoms" (LUTS) seems to be an age independent risk factor. In contrast, the prevalence of ED in healthy men was around 6,6 %.
  
  
  CONCLUSIONS
  ED is a common disorder, contributing to dissatisfaction with sex life in a considerable proportion of men. ED is frequently associated with chronic diseases. For this reason adequate interdisciplinary diagnostic workup is essential, to offer patients individually adapted treatment.
authors.affiliation: Klinik und Poliklinik für Urologie, Klinikum der Universität zu Köln, Germany. Moritz.Braun@medizin.uni-koeln.de
authors.forename: M
authors.initials: M
authors.lastname: Braun
authors.forename: F
authors.initials: F
authors.lastname: Sommer
authors.forename: W
authors.initials: W
authors.lastname: Lehmacher
authors.forename: A
authors.initials: A
authors.lastname: Raible
authors.forename: B
authors.initials: B
authors.lastname: Bondarenko
authors.forename: U
authors.initials: U
authors.lastname: Engelmann
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D048909:Diabetes Complications; D007172:Erectile Dysfunction / Q000453:epidemiology* / Q000209:etiology* / Q000523:psychology; D005858:Germany / Q000453:epidemiology; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D007405:Intervertebral Disc Displacement / Q000150:complications; D008297:Male; D008875:Middle Aged; D010388:Pelvis / Q000601:surgery; D016491:Peripheral Vascular Diseases / Q000150:complications; D015995:Prevalence; D011788:Quality of Life / Q000523:psychology; D012307:Risk Factors; D012725:Sexual Behavior / Q000523:psychology; D011795:Surveys and Questionnaires; D014505:Urban Population; D014555:Urination Disorders / Q000150:complications
chemical_list: D000319:Adrenergic beta-Antagonists